Rapid bioanalysis of vancomycin in serum and urine by high-performance liquid chromatography tandem mass spectrometry using on-line sample extraction and parallel analytical columns

被引:61
作者
Cass, RT [1 ]
Villa, JS [1 ]
Karr, DE [1 ]
Schmidt, DE [1 ]
机构
[1] Adv Med Inc, Dept Bioanalyt Chem, S San Francisco, CA 94080 USA
关键词
D O I
10.1002/rcm.246
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A novel high-performance liquid chromatography tandem mass spectrometry (LC/MS/MS) method is described for the determination of vancomycin in serum and urine. After the addition of internal standard (teicoplanin), serum and urine samples were directly injected onto an HPLC system consisting of an extraction column and dual analytical columns. The columns are plumbed through two switching valves. A six-port valve directs extraction column effluent either to waste or to an analytical column. A ten-port valve simultaneously permits equilibration of one analytical column while the other is used for sample analysis. Thus, off-line analytical column equilibration time does not require mass spectrometer time, freeing the detector for increased sample throughput. The online sample extraction step takes 15 seconds followed by gradient chromatography taking another 90 seconds. Having minimal sample pretreatment the method is both simple and fast. This system has been used to successfully develop a validated positive-ion electrospray bioanalytical method for the quantitation of vancomycin. Detection of vancomycin was accurate and precise, with a limit of detection of 1 ng/mL in serum and urine. The calibration curves for vancomycin in rat, dog and primate were linear in a concentration range of 0.001-10 mug/mL for serum and urine. This method has been successfully applied to determine the concentration of vancomycin in rat, dog and primate serum and urine samples from pharmacokinetic and urinary excretion studies. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 28 条
  • [1] Glycopeptide resistance in enterococci
    Arthur, M
    Reynolds, P
    Courvalin, P
    [J]. TRENDS IN MICROBIOLOGY, 1996, 4 (10) : 401 - 407
  • [2] Ayrton J, 1997, RAPID COMMUN MASS SP, V11, P1953, DOI 10.1002/(SICI)1097-0231(199712)11:18<1953::AID-RCM102>3.0.CO
  • [3] 2-Z
  • [4] Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms
    Beauregard, DA
    Maguire, AJ
    Williams, DH
    Reynolds, PE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2418 - 2423
  • [5] TEICOPLANIN METABOLISM IN HUMANS
    BERNAREGGI, A
    BORGHI, A
    BORGONOVI, M
    CAVENAGHI, L
    FERRARI, P
    VEKEY, K
    ZANOL, M
    ZERILLI, LF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) : 1744 - 1749
  • [6] SEVERE STAPHYLOCOCCAL INFECTIONS TREATED WITH VANCOMYCIN
    CAFFERKEY, MT
    HONE, R
    KEANE, CT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 9 (01) : 69 - 74
  • [7] Reductive alkylation of glycopeptide antibiotics: Synthesis and antibacterial activity
    Cooper, RDG
    Snyder, NJ
    Zweifel, MJ
    Staszak, MA
    Wilkie, SC
    Nicas, TI
    Mullen, DL
    Butler, TF
    Rodriguez, MJ
    Huff, BE
    Thompson, RC
    [J]. JOURNAL OF ANTIBIOTICS, 1996, 49 (06) : 575 - 581
  • [8] COLUMN-SWITCHING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF VANCOMYCIN IN SERUM
    DEMOTESMAINARD, F
    LABAT, L
    VINCON, G
    BANNWARTH, B
    [J]. THERAPEUTIC DRUG MONITORING, 1994, 16 (03) : 293 - 297
  • [9] GERACI JE, 1983, MAYO CLIN PROC, V58, P88
  • [10] GERACI JE, 1977, MAYO CLIN PROC, V52, P631